Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Jinsheng Weng, Cao Cuong Le, Yong Pan, Francesca Perutelli, Xiaoyun Cheng, Jingjing Cao, Owhofasa Agbedia, Shao-Qing Kuang, Jingwei Liu, Fuliang Chu, Sridevi Patchva, Neeraj Y. Saini, Sattva S. Neelapu

Blood (2023) 142 (Supplement 1): 6827.

https://doi.org/10.1182/blood-2023-180028

Published: 2023

Journal Articles

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Jinsheng Weng, MD PhD, Kelsey Moriarty, BD, Yong Pan, Man Chun John MA, PhD, Rohit Mathur, PhD, Zheng Zhang, Hiroki Torikai, MD, Sourindra N Maiti, Fuliang Chu, PhD, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J N Cooper, MD PhD, R. Eric Davis, MD, Sattva S. Neelapu, MD

Blood (2018) 132 (Supplement 1): 3488.

https://doi.org/10.1182/blood-2018-99-115424

Published: 2018

Journal Articles

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Fuliang Chu, PhD, Jinsheng Weng, MD PhD, Shao-Qing Kuang, PhD, Xiaoyun Cheng, JingJing Cao, Jingwei Liu, MD, Swathi Karri, Adithi Reddy, Sattva S. Neelapu, MD

Blood (2018) 132 (Supplement 1): 1662.

https://doi.org/10.1182/blood-2018-99-119009

Published: 2018

Journal Articles

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Loretta Nastoupil, MD, Jason R. Westin, MD, Nathan H. Fowler, MD, Michelle A. Fanale, MD, Felipe Samaniego, MD, Yasuhiro Oki, MD, Ly Dsouza, PA-C, Chizobam Obi, RN, JingJing Cao, Xiaoyun Cheng, Man Chun John MA, PhD, Wang Zhiqiang, Lei Feng, MS, Shouhao Zhou, R. Eric Davis, MD, Sattva S. Neelapu, MD

Blood (2017) 130 (Supplement 1): 414.

https://doi.org/10.1182/blood.V130.Suppl_1.414.414

Published: 2017

Journal Articles

Intratumoral and Peripheral Blood T Cells Recognize Mutated Neo-Antigens in Follicular Lymphoma

Seung Tae Lee, MD PhD, Elena Percivalle, PhD, Xiaoyun Cheng, Greg Lizee, PhD, Nathan Fowler, MD, R Eric Davis, MD, Sattva S Neelapu, MD

Blood (2014) 124 (21): 809.

https://doi.org/10.1182/blood.V124.21.809.809

Published: 2014

NARROW

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Intratumoral and Peripheral Blood T Cells Recognize Mutated Neo-Antigens in Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Intratumoral and Peripheral Blood T Cells Recognize Mutated Neo-Antigens in Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only